Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EBIT Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 21.2241.65-15.6018.7817.23

What is the latest EBIT Growth ratio of MANKIND PHARMA ?

The latest EBIT Growth ratio of MANKIND PHARMA is 21.22 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202521.22
Mar202441.65
Mar2023-15.60
Mar202218.78
Mar202117.23

How is EBIT Growth of MANKIND PHARMA Trending?

Years EBIT Growth % Change
Mar2025 21.22
-49.05
Mar2024 41.65
Positive
Mar2023 -15.6
Negative
Mar2022 18.78
9.00
Mar2021 17.23 -

Other Financial Ratios of MANKIND PHARMA


Compare EBIT Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹99,148.4 Cr -0.1% -1.5% -5.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,626.0 Cr 1.2% 4.4% -9.7% Stock Analytics
DIVIS LABORATORIES ₹180,669.0 Cr 5.8% 19.2% 16.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 1.4% 1.8% 10.8% Stock Analytics
CIPLA ₹122,103.0 Cr -3.7% -0.2% 1.6% Stock Analytics
DR REDDYS LABORATORIES ₹99,857.4 Cr -7.3% -4% -6.1% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.1%

-1.5%

-5.7%

SENSEX

-0.9%

4.6%

5%


You may also like the below Video Courses